204 related articles for article (PubMed ID: 27381221)
1. Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG).
Siddiqui MR; Gormly KL; Bhoday J; Balyansikova S; Battersby NJ; Chand M; Rao S; Tekkis P; Abulafi AM; Brown G
Clin Radiol; 2016 Sep; 71(9):854-62. PubMed ID: 27381221
[TBL] [Abstract][Full Text] [Related]
2. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.
Sclafani F; Brown G; Cunningham D; Wotherspoon A; Mendes LST; Balyasnikova S; Evans J; Peckitt C; Begum R; Tait D; Tabernero J; Glimelius B; Roselló S; Thomas J; Oates J; Chau I
Br J Cancer; 2017 Nov; 117(10):1478-1485. PubMed ID: 28934761
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Tumor Regression Grade on MR in Rectal Cancer: A Large-Scale, Single-Center Experience.
Yoen H; Park HE; Kim SH; Yoon JH; Hur BY; Bae JS; Kim JH; Oh HJ; Han JK
Korean J Radiol; 2020 Sep; 21(9):1065-1076. PubMed ID: 32691542
[TBL] [Abstract][Full Text] [Related]
4. MRI tumour regression grade in locally recurrent rectal cancer.
Voogt ELK; Nordkamp S; van Zoggel DMGI; Daniëls-Gooszen AW; Nieuwenhuijzen GAP; Bloemen JG; Creemers GJ; Cnossen JS; van Lijnschoten G; Burger JWA; Rutten HJT; Nederend J
BJS Open; 2022 May; 6(3):. PubMed ID: 35552373
[TBL] [Abstract][Full Text] [Related]
5. A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.
Battersby NJ; Dattani M; Rao S; Cunningham D; Tait D; Adams R; Moran BJ; Khakoo S; Tekkis P; Rasheed S; Mirnezami A; Quirke P; West NP; Nagtegaal I; Chong I; Sadanandam A; Valeri N; Thomas K; Frost M; Brown G
Trials; 2017 Aug; 18(1):394. PubMed ID: 28851403
[TBL] [Abstract][Full Text] [Related]
6. Modified 3-Point MRI-Based Tumor Regression Grade Incorporating DWI for Locally Advanced Rectal Cancer.
Lee MA; Cho SH; Seo AN; Kim HJ; Shin KM; Kim SH; Choi GS
AJR Am J Roentgenol; 2017 Dec; 209(6):1247-1255. PubMed ID: 28981353
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of MRI in Restaging Locally Advanced Rectal Cancer After Preoperative Chemoradiation.
van den Broek JJ; van der Wolf FS; Lahaye MJ; Heijnen LA; Meischl C; Heitbrink MA; Schreurs WH
Dis Colon Rectum; 2017 Mar; 60(3):274-283. PubMed ID: 28177989
[TBL] [Abstract][Full Text] [Related]
8. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer.
Patel UB; Brown G; Rutten H; West N; Sebag-Montefiore D; Glynne-Jones R; Rullier E; Peeters M; Van Cutsem E; Ricci S; Van de Velde C; Kjell P; Quirke P
Ann Surg Oncol; 2012 Sep; 19(9):2842-52. PubMed ID: 22526897
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of MRI in assessing extramural venous invasion in rectal cancer: multi-readers' diagnostic performance.
Bae JS; Kim SH; Hur BY; Chang W; Park J; Park HE; Kim JH; Kang HJ; Yu MH; Han JK
Eur Radiol; 2019 Aug; 29(8):4379-4388. PubMed ID: 30617483
[TBL] [Abstract][Full Text] [Related]
10. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales.
Siddiqui MR; Bhoday J; Battersby NJ; Chand M; West NP; Abulafi AM; Tekkis PP; Brown G
World J Gastroenterol; 2016 Oct; 22(37):8414-8434. PubMed ID: 27729748
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience.
Nougaret S; Fujii S; Addley HC; Bibeau F; Pandey H; Mikhael H; Reinhold C; Azria D; Rouanet P; Gallix B
J Magn Reson Imaging; 2013 Sep; 38(3):726-32. PubMed ID: 23152299
[TBL] [Abstract][Full Text] [Related]
12. Interpretation of Complete Tumor Response on MRI Following Chemoradiotherapy of Rectal Cancer: Inter-Reader Agreement and Associated Factors in Multi-Center Clinical Practice.
Kim HY; Cho SH; Jang JK; Kim B; Lee CM; Lim JS; Moon SK; Oh SN; Seo N; Park SH
Korean J Radiol; 2024 Apr; 25(4):351-362. PubMed ID: 38528693
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a multiparametric MRI scoring system for histopathologic treatment response following preoperative chemoradiotherapy for rectal cancer.
Khwaja SA; Thipphavong S; Kirsch R; Menezes RJ; Kennedy ED; Brierley JD; Jhaveri KS
Eur J Radiol; 2021 May; 138():109628. PubMed ID: 33721764
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of 3.0-tesla high-resolution magnetic resonance imaging for invasion depth of rectal cancer].
Yao X; Song X; Wang Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):668-74. PubMed ID: 27353102
[TBL] [Abstract][Full Text] [Related]
15. Can CT replace MRI in preoperative assessment of the circumferential resection margin in rectal cancer?
Maizlin ZV; Brown JA; So G; Brown C; Phang TP; Walker ML; Kirby JM; Vora P; Tiwari P
Dis Colon Rectum; 2010 Mar; 53(3):308-14. PubMed ID: 20173478
[TBL] [Abstract][Full Text] [Related]
16. Intra- and interobserver agreement of rectal cancer staging with MRI.
Kilickap G; Dolek BA; Ercan K
Acta Radiol; 2023 May; 64(5):1747-1754. PubMed ID: 36476121
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer.
Suppiah A; Hunter IA; Cowley J; Garimella V; Cast J; Hartley JE; Monson JR
Colorectal Dis; 2009 Mar; 11(3):249-53. PubMed ID: 18513192
[TBL] [Abstract][Full Text] [Related]
18. Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients.
Cho MS; Kim H; Han YD; Hur H; Min BS; Baik SH; Cheon JH; Lim JS; Lee KY; Kim NK
Medicine (Baltimore); 2019 Aug; 98(35):e16614. PubMed ID: 31464897
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Baseline Rectal Tumor Length and Magnetic Resonance Tumor Regression Grade Response to Chemoradiotherapy: A Subanalysis of the TRIGGER Feasibility Study.
Hodges N; Battersby N; Rao S; Brown G;
Ann Surg Oncol; 2023 Aug; 30(8):4729-4735. PubMed ID: 35771366
[TBL] [Abstract][Full Text] [Related]
20. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer.
Kim YC; Lim JS; Keum KC; Kim KA; Myoung S; Shin SJ; Kim MJ; Kim NK; Suh J; Kim KW
J Magn Reson Imaging; 2011 Sep; 34(3):570-6. PubMed ID: 21751285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
